A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
I-Mab Biopharma US Limited
I-Mab Biopharma US Limited
M.D. Anderson Cancer Center
Astellas Pharma Inc
Merck Sharp & Dohme LLC
Novartis
Zhejiang Provincial People's Hospital
TJ Biopharma Co., Ltd.